Neurocrine BiosciencesvsUnitedHealth

NBIX and UNH stock compared: price, dividend, valuation and results, from SEC filings.

NBIX

Neurocrine Biosciences, Inc.

$156.59

Value $15.7B

-3.85%
NBIX's page

UNH

UnitedHealth Group Incorporated

$330.48

Value $300B

-5.55%
UNH's page

Neurocrine Biosciences (NBIX) has a market value of $15.7B and UnitedHealth (UNH) $300B. Over the last year, with dividends, NBIX moved +13.0% and UNH +8.2%. The P/E is 22.4 for NBIX and 18.9 for UNH. Dividend yield: NBIX none, UNH 2.74%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NBIX$15.7B

    UNH$300B

    UNH is 19 times NBIX

  • Revenue, 12 months

    NBIX$3.7B

    UNH$450B

    UNH is 121 times NBIX

  • Net income, 12 months

    NBIX$703M

    UNH$15.9B

    UNH is 23 times NBIX

  • Operating margin

    NBIX24.0%

    UNH5.3%

    18.7 points apart

  • ROIC

    NBIX19.4%

    UNH11.3%

    8.1 points apart

  • P/E

    NBIX22.4

    UNH18.9

    NBIX is 1.2 times UNH

  • Dividend yield

    NBIX0.0%

    UNH2.7%

    2.7 points apart

  • 5-year return

    NBIX+78.9%

    UNH-19.5%

    98.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NBIX+78.9%

UNH-19.5%

5010015020020222023202420252026
Returns by period
PeriodNBIXWith dividendsUNHWith dividends
1 year since November 18, 2025+13.0%Price +13.0%+8.2%Price +5.4%
3 years since November 17, 2023+43.7%+12.9% a yearPrice +43.7%-34.4%-13.1% a yearPrice -38.4%
5 years since November 18, 2021+78.9%+12.3% a yearPrice +78.9%-19.5%-4.2% a yearPrice -26.5%
10 years since November 21, 2016+207.7%+11.9% a yearPrice +207.7%+159.4%+10.0% a yearPrice +119.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NBIXNeurocrine BiosciencesUNHUnitedHealth

Valuation

NBIXUNH
Valuation
Price$156.59$330.48
Market value$15.7B$300B
Enterprise value (EV)$15.0B$346B
P/E22.418.9
P/E, 5-year median53.325.0
P/B4.12.9
EV/EBIT16.914.5
Free cash flow yield6.6%7.6%

Results and growth

NBIXUNH
Results and growth
Revenue, 12 months$3.7B$450B
Net income, 12 months$703M$15.9B
Free cash flow, 12 months$1.0B$22.8B
Earnings per share, 12 months$6.74$17.52
Revenue growth, year on year21.5%11.8%
Revenue growth a year, past+22.3%over 5 years+11.7%over 5 years
EPS growth a year, past+2.3%over 5 years-3.8%over 5 years

Margins and returns on capital

NBIXUNH
Margins and returns on capital
Gross margin97.8%88.3%
Operating margin24.0%5.3%
Net margin19.0%3.5%
ROIC19.4%11.3%
ROE20.4%15.5%

Balance sheet

NBIXUNH
Balance sheet
Cash$738M$28.5B
Total debt$452M$74.3B
Net debt / EBITDA-0.81.6
Interest cover–6.2×

Dividends and buybacks

NBIXUNH
Dividends and buybacks
Dividend yield–2.7%
Dividend per share, 12 months–$9.06
Dividend growth a year, past–+12.6%over 5 years
Buyback yield1.1%1.8%
Shareholder yield1.1%4.6%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NBIX or UNH

Didn't find what you were looking for?

Ask us
Which is bigger, Neurocrine Biosciences or UnitedHealth?

By market value, UnitedHealth ($300B) is about 19.1 times Neurocrine Biosciences ($15.7B), at today's prices.

How did NBIX and UNH stock do over the last 10 years?

Since November 21, 2016, NBIX's price moved +207.7% and UNH's +119.7%. With dividends: NBIX +207.7% (+11.9% a year), UNH +159.4% (+10.0% a year). Past returns do not predict future ones.

Which pays the higher dividend, NBIX or UNH?

The dividend yield at today's price is none for Neurocrine Biosciences and 2.74% for UnitedHealth. Over the last twelve months they paid – and $9.06 per share.

What is the P/E of NBIX and UNH?

At today's price, the P/E is 22.4 for NBIX and 18.9 for UNH. The median of the last five years was 53.3 and 25.0, which shows where each stands against its own past.

Which has the higher profit margins, Neurocrine Biosciences or UnitedHealth?

Over the last twelve months, the net margin was 19.0% for Neurocrine Biosciences and 3.5% for UnitedHealth, and the operating margin 24.0% and 5.3%. Revenue was $3.7B and $450B.

Which is the better investment, Neurocrine Biosciences or UnitedHealth?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.